Galectin Therapeutics, Inc. (GALT)
4.04
-0.10
(-2.42%)
USD |
NASDAQ |
Sep 09, 15:07
Galectin Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2022 | 277.17 |
| March 29, 2022 | 275.55 |
| March 28, 2022 | 269.07 |
| March 25, 2022 | 282.04 |
| March 24, 2022 | 286.90 |
| March 23, 2022 | 291.76 |
| March 22, 2022 | 296.63 |
| March 21, 2022 | 285.28 |
| March 18, 2022 | 299.87 |
| March 17, 2022 | 301.49 |
| March 16, 2022 | 280.42 |
| March 15, 2022 | 282.04 |
| March 14, 2022 | 283.66 |
| March 11, 2022 | 285.28 |
| March 10, 2022 | 290.14 |
| March 09, 2022 | 296.63 |
| March 08, 2022 | 286.90 |
| March 07, 2022 | 283.66 |
| March 04, 2022 | 294.19 |
| March 03, 2022 | 293.38 |
| March 02, 2022 | 296.63 |
| March 01, 2022 | 303.11 |
| February 28, 2022 | 303.11 |
| February 25, 2022 | 307.97 |
| February 24, 2022 | 320.94 |
| Date | Value |
|---|---|
| February 23, 2022 | 303.11 |
| February 22, 2022 | 314.46 |
| February 18, 2022 | 324.18 |
| February 17, 2022 | 325.80 |
| February 16, 2022 | 345.25 |
| February 15, 2022 | 335.53 |
| February 14, 2022 | 322.56 |
| February 11, 2022 | 337.15 |
| February 10, 2022 | 335.53 |
| February 09, 2022 | 343.63 |
| February 08, 2022 | 337.15 |
| February 07, 2022 | 348.49 |
| February 04, 2022 | 346.87 |
| February 03, 2022 | 333.91 |
| February 02, 2022 | 351.74 |
| February 01, 2022 | 343.63 |
| January 31, 2022 | 312.83 |
| January 28, 2022 | 296.63 |
| January 27, 2022 | 295.00 |
| January 26, 2022 | 303.11 |
| January 25, 2022 | 309.59 |
| January 24, 2022 | 320.94 |
| January 21, 2022 | 311.21 |
| January 20, 2022 | 329.04 |
| January 19, 2022 | 325.80 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.666 |
| Alnylam Pharmaceuticals, Inc. | 25.30 |
| Anika Therapeutics, Inc. | 2.038 |
| Savara, Inc. | 7.706 |
| Vericel Corp. | 5.399 |
Price to Book Value Related Metrics
| Price | 4.04 |
| Earnings Yield | -10.64% |
| Market Cap | 267.90M |